On May 18, 2023, the United States Supreme Court decided Amgen Inc et al.. Sanofi et al., a case on patents covering antibodies engineered by scientists that help reduce levels of low-density lipoprotein cholesterol.  While the technology at issue was new, the Court relied on its precedent dating back nearly 170 years ago to unanimously … Continue reading Amgen Supreme Court decision: Citing to The Telegraph and Light Bulb Patent Battles